← HERON THERAPEUTICS, INC. /DE/
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $13.4m | $144.6m | $31.8m | $71.9m | $105.1m | $90.5m | $15.4m | $28.7m | $25.8m | $28.6m | |
| Prepaid Expense and Other Assets, Current | $3.7m | $3.7m | $11.2m | $23.2m | $21.9m | $13.0m | $14.0m | $6.1m | $17.7m | $9.1m | |
| Cash, Cash Equivalents, and Short-term Investments | $51.1m | $172.4m | $332.4m | $391.0m | $208.5m | $157.6m | $84.9m | $80.4m | $59.3m | $46.6m | |
| Inventory, Net | $5.3m | $10.1m | $39.0m | $25.0m | $41.9m | $48.4m | $54.6m | $42.1m | $53.2m | $92.7m | |
| Assets, Current | $62.1m | $228.1m | $447.2m | $479.1m | $314.2m | $254.4m | $205.4m | $188.8m | $209.0m | $238.1m | |
| Property, Plant and Equipment, Net | $5.1m | $6.0m | $14.7m | $19.6m | $22.7m | $23.7m | $22.2m | $20.2m | $14.9m | $12.4m | |
| Operating Lease, Right-of-Use Asset | — | — | — | $13.8m | $16.3m | $9.8m | $7.6m | $5.4m | $2.8m | $0 | |
| Other Assets, Noncurrent | $263k | $263k | $254k | $346k | $346k | $17.7m | $15.7m | $8.1m | $6.5m | $5.4m | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | $2.0m | $41.9m | $64.7m | $39.9m | $41.9m | $35.5m | $52.0m | $60.1m | $78.9m | $89.6m | |
| Assets | $67.5m | $234.3m | $462.2m | $512.8m | $353.6m | $305.7m | $251.0m | $222.5m | $233.1m | $255.9m | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $1.9m | $3.0m | $2.4m | $2.7m | $3.1m | $3.0m | $0 | |
| Accounts Payable, Current | $6.8m | $18.8m | $16.9m | $2.8m | $525k | $3.8m | $3.2m | $3.2m | $11.7m | $9.0m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $12.2m | $14.6m | $8.0m | $5.5m | $2.8m | — | — | |
| Deferred Revenue, Current | $1.1m | $2.8m | — | — | — | — | — | — | — | — | |
| Liabilities, Current | $38.7m | $103.2m | $92.0m | $96.7m | $102.5m | $71.1m | $82.4m | $79.7m | $91.5m | $96.1m | |
| Other Liabilities, Noncurrent | — | — | — | — | — | — | $241k | $241k | $615k | $4.8m | |
| Liabilities | $88.7m | $103.2m | — | $108.9m | $117.1m | $228.1m | $237.4m | $256.5m | $266.8m | $241.5m | |
| Stockholders’ equity: | |||||||||||
| Preferred Stock, Value, Issued | $0 | — | — | — | — | — | — | — | $0 | $1.1m | |
| Common Stock, Value, Issued | $394k | $646k | $782k | $903k | $913k | $1.0m | $1.2m | $1.5m | $1.5m | $1.9m | |
| Additional Paid in Capital | $564.3m | $914.0m | $1.3b | $1.6b | $1.6b | $1.7b | $1.8b | $1.9b | $1.9b | $2.0b | |
| Retained Earnings (Accumulated Deficit) | ($586.0m) | ($783.5m) | ($960.7m) | ($1.2b) | ($1.4b) | ($1.6b) | ($1.8b) | ($1.9b) | ($1.9b) | ($1.9b) | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | ($17k) | ($10k) | ($87k) | $85k | $257k | ($6k) | ($19k) | $13k | $13k | $4k | |
| Stockholders' Equity Attributable to Parent | ($21.3m) | $131.1m | $370.2m | $403.8m | $236.5m | $77.6m | $13.6m | ($34.0m) | ($33.7m) | $14.3m | |
| Liabilities and Equity | $67.5m | $234.3m | $462.2m | $512.8m | $353.6m | $305.7m | $251.0m | $222.5m | $233.1m | $255.9m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.